181 related articles for article (PubMed ID: 15987828)
1. Chronic morphine up-regulates G alpha12 and cytoskeletal proteins in Chinese hamster ovary cells expressing the cloned mu opioid receptor.
Xu H; Wang X; Zimmerman D; Boja ES; Wang J; Bilsky EJ; Rothman RB
J Pharmacol Exp Ther; 2005 Oct; 315(1):248-55. PubMed ID: 15987828
[TBL] [Abstract][Full Text] [Related]
2. Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.
Xu H; Lu YF; Rothman RB
Synapse; 2003 Jan; 47(1):1-9. PubMed ID: 12422367
[TBL] [Abstract][Full Text] [Related]
3. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
4. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
5. Intracellular cAMP assay and Eu-GTP-γS binding studies of chimeric opioid peptide YFa.
Kumar K; Kumar S; Kurupati RK; Seth MK; Mohan A; Hussain ME; Pasha S
Eur J Pharmacol; 2011 Jan; 650(1):28-33. PubMed ID: 20887721
[TBL] [Abstract][Full Text] [Related]
6. Modulation of agmatine on calcium signal in morphine-dependent CHO cells by activation of IRAS, a candidate for imidazoline I1 receptor.
Wu N; Su RB; Liu Y; Lu XQ; Zheng JQ; Cong B; Li J
Eur J Pharmacol; 2006 Oct; 548(1-3):21-8. PubMed ID: 16962578
[TBL] [Abstract][Full Text] [Related]
7. Chronic morphine treatment increases stimulatory beta-2 adrenoceptor signaling in A431 cells stably expressing the mu opioid receptor.
Ammer H; Schulz R
J Pharmacol Exp Ther; 1997 Jan; 280(1):512-20. PubMed ID: 8996236
[TBL] [Abstract][Full Text] [Related]
8. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
9. Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence.
Wang D; Raehal KM; Lin ET; Lowery JJ; Kieffer BL; Bilsky EJ; Sadée W
J Pharmacol Exp Ther; 2004 Feb; 308(2):512-20. PubMed ID: 14600246
[TBL] [Abstract][Full Text] [Related]
10. Biochemical demonstration of mu-opioid receptor association with Gsalpha: enhancement following morphine exposure.
Chakrabarti S; Regec A; Gintzler AR
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):217-24. PubMed ID: 15857684
[TBL] [Abstract][Full Text] [Related]
11. Chronic antidepressant treatment causes a selective reduction of mu-opioid receptor binding and functional coupling to G Proteins in the amygdala of fawn-hooded rats.
Chen F; Lawrence AJ
J Pharmacol Exp Ther; 2004 Sep; 310(3):1020-6. PubMed ID: 15121763
[TBL] [Abstract][Full Text] [Related]
12. Functional coupling of a mu opioid receptor to G proteins and adenylyl cyclase: modulation by chronic morphine treatment.
Chen Y; Liu J; Yu L
Addict Biol; 1996; 1(1):49-59. PubMed ID: 12893486
[TBL] [Abstract][Full Text] [Related]
13. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
Clark MJ; Traynor JR
J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
[TBL] [Abstract][Full Text] [Related]
14. Mu-delta opioid receptor functional interaction: Insight using receptor-G protein fusions.
Snook LA; Milligan G; Kieffer BL; Massotte D
J Pharmacol Exp Ther; 2006 Aug; 318(2):683-90. PubMed ID: 16690720
[TBL] [Abstract][Full Text] [Related]
15. Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia.
Guang W; Wang H; Su T; Weinstein IB; Wang JB
Mol Pharmacol; 2004 Nov; 66(5):1285-92. PubMed ID: 15496510
[TBL] [Abstract][Full Text] [Related]
16. Morphine desensitization, internalization, and down-regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation.
Lopez-Gimenez JF; Vilaró MT; Milligan G
Mol Pharmacol; 2008 Nov; 74(5):1278-91. PubMed ID: 18703670
[TBL] [Abstract][Full Text] [Related]
17. Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo.
Yoburn BC; Gomes BA; Rajashekara V; Patel C; Patel M
Synapse; 2003 Feb; 47(2):109-16. PubMed ID: 12454948
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic opioid exposure on guinea pig mu opioid receptor in Chinese hamster ovary cells: comparison with human and rat receptor.
Wallisch M; Nelson CS; Mulvaney JM; Hernandez HS; Smith SA; Olsen GD
Biochem Pharmacol; 2007 Jun; 73(11):1818-28. PubMed ID: 17343833
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of mu opioid receptor/G-protein desensitization in brain by chronic heroin administration.
Maher CE; Martin TJ; Childers SR
Life Sci; 2005 Jul; 77(10):1140-54. PubMed ID: 15890372
[TBL] [Abstract][Full Text] [Related]
20. Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors.
Thompson CM; Wojno H; Greiner E; May EL; Rice KC; Selley DE
J Pharmacol Exp Ther; 2004 Feb; 308(2):547-54. PubMed ID: 14600248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]